This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prion strain variation and the type of CJD

Authoring team

Investigation into the nature of prions found in different diseases shows that there exists a variety of types or "strains" of prion protein. These strains appear to differ from eachother in animal prion disease by their differing incubation times, patterns of neuropathology and differing susceptibilty to proteolysis and subsequent migration patterns on polyacrylamide gel.

Study of human prion disease has revealed that prions found in human disease may be characterised into 4 types.

Types 1 and 2 are found in sporadic classical CJD and also in some iatrogenic cases.

Type 3 prions are found in iatrogenic cases of CJD, such as hormonal therapy where infection is acquired by peripheral injection.

Examining cases of the new variant CJD revealed a distinct new fourth type or strain of prion protein - appears particularly protease resistant and whose western blot suggests glycosylation of the protein.

  • this fourth type of prion protein resemble closely those of bovine spongiform encephalopathy transmitted to mice, domestic cats and macaque monkeys

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.